摘要 |
<p>The present invention relates to novel l,2-dihydro-2-oxoquinoline compounds of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. Formula (I) The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The compounds of the present invention are useful in the treatment/prevention of various disorders that are mediated by 5-HT4 receptor activity.</p> |
申请人 |
SUVEN LIFE SCIENCES LIMITED |
发明人 |
NIROGI, RAMAKRISHNA;MOHAMMED, ABDUL RASHEED;AHMAD, ISHTIYAQUE;JAYARAJAN, PRADEEP;KANDIKERE, NAGARAJ VISHWOTTAM;SHINDE, ANIL KARBHARI;KAMBHAMPATI, RAMA SASTRI;BHYRAPUNENI, GOPINADH;RAVULA, JYOTHSNA;PATNALA, SRIRAMACHANDRA MURTHY;JASTI, VENKATESWARLU |